The duration of diabetes and advancing age independently predict diabetes severity and risk of death in older adults with type 2 diabetes according to a recent study.
Researchers report that morbidity following liver transplant is highest among obese patients with diabetes, but these risk factors do not influence post-transplant survival.
Type 2 diabetics often assume that their glucose response at one meal will be identical to their responses at other meals, but that really...
New studies are needed to assess the trade-offs between potential benefits and potential harms when rosiglitazone is used by people with type 2 diabetes.
Researchers may have found a novel way to suppress the devastating side effect of one of the worlds' most widely used drugs to lower cholesterol and prevent heart disease.
A group of researchers has discovered that a diet rich in soy protein may alleviate fatty liver, a disease which often accompanies diabetes.
The genome of patients with type 2 diabetes (DT2) has been elucidated, for the first time, thanks to the use of new DNA chip technologies allowing 400,000 DNA mutations to be studied simultaneously.
Exposure to air pollution has an especially negative impact on people with diabetes, which includes worsening blood sugar levels. Exposure to air pollution can worsen...
The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain, the burning or tingling pain in the hands and feet that affects millions of people with diabetes.
Preliminary research suggests that use of the anti-malarial drug hydroxychloroquine may help reduce the risk of the development of diabetes in patients with rheumatoid arthritis.
Human insulin is as safe and effective to treat type 2 diabetes as costlier insulin analogs, according to Yale researchers.
According to a new study, low blood glucose levels in hospitalized patients is linked to increased mortality risk, but a new guide has...
A new review of studies confirms that the drug metformin should be in the first line of defense against type 2 diabetes.
A new study reveals critical molecular events in the origin of fat cells. The findings are central to understanding chronic diseases, such as obesity and diabetes, as fat cells produce hormones critical for metabolic control, the researchers said.
The FDA approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
Scientists have discovered that electric stimulation of the brain regulated the metabolism of blood sugar (or glucose) and increased insulin sensitivity.